Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United States/Pemvidutide
Purchase and availability checkPemvidutide in the United States

Can you buy Pemvidutide in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Pemvidutide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United States
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Pemvidutide in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Pemvidutide is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Pemvidutide in United States?

Resolve the exact identity of Pemvidutide through IMPACT Phase 2b MASH study - NCT05989711 from ClinicalTrials.gov. Then search Drugs@FDA approved drug database from U.S. Food and Drug Administration for the destination product record and Locate a state-licensed online pharmacy from U.S. Food and Drug Administration for the seller, establishment, or supply route in United States. A match in one record does not replace the other two checks.

03

Does an online listing prove Pemvidutide is authorized or available in United States?

No. A page using the name Pemvidutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United States, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Pemvidutide clinical trials in United States

7 study records currently list 149 locations in this country, including 8 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
7
Listed locations
149
Recruiting locations
8
Records with local recruiting sites
1
NCT07009860
Study-wide statusRecruiting

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Listed locations
42
Recruiting locations
8
Registry update
2026-03-20
NCT05989711
Study-wide statusCompleted

IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

Listed locations
29
Recruiting locations
0
Registry update
2026-05-18
NCT06987513
Study-wide statusActive, not recruiting

RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Listed locations
12
Recruiting locations
0
Registry update
2025-11-19
NCT05134662
Study-wide statusCompleted

ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)

Listed locations
7
Recruiting locations
0
Registry update
2025-06-24
NCT05295875
Study-wide statusCompleted

Efficacy and Safety of ALT-801 in the Treatment of Obesity

Listed locations
31
Recruiting locations
0
Registry update
2023-11-29
NCT05006885
Study-wide statusCompleted

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Listed locations
15
Recruiting locations
0
Registry update
2023-07-27
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United States, or keep Pemvidutide fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

Pemvidutide in North America

Pemvidutide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Pemvidutide is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: IMPACT Phase 2b MASH study - NCT05989711 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

IMPACT Phase 2b MASH study - NCT05989711

IMPACT Phase 2b MASH study - NCT05989711 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open IMPACT Phase 2b MASH study - NCT05989711 ↗

Drugs@FDA approved drug database

Drugs@FDA approved drug database is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drugs@FDA approved drug database ↗

Locate a state-licensed online pharmacy

Locate a state-licensed online pharmacy is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Locate a state-licensed online pharmacy ↗
United States / Country guide

United States market context.

A US peptide search can surface prescription drugs, compounded preparations, telehealth offers, and laboratory-research materials in one result set. Federal and state records answer different questions, so no single lookup validates every route.

  • FDA’s BeSafeRx directory sends consumers to each state board’s pharmacy-license database and says an unlisted online pharmacy should not be used.
  • Sections 503A and 503B apply different conditions to compounding from bulk drug substances; FDA updates the underlying lists and policies as substances are evaluated.
  • FDA’s peptide-related bulk-substance page identifies limited information or potential safety concerns for several names that also appear in research and wellness marketing.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Start with the seller class

For an online pharmacy claim, use FDA’s state-license directory to reach the relevant board database and match the business, address, and current license before comparing price.

02

Separate the federal record

Check FDA approval, shortage, outsourcing-facility, and bulk-substance records separately; a state pharmacy license does not make every product or compounding claim federally supported.

03

Keep research outside care

A laboratory-research listing is not a prescription pathway. Compare only like-for-like catalog rows and retain the research-only boundary, source date, shipping claim, and evidence-access label.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05989711: IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)ClinicalTrials.gov
02
Drugs@FDA approved drug databaseU.S. Food and Drug Administration
03
Locate a state-licensed online pharmacyU.S. Food and Drug Administration
04
Bulk drug substances used in compoundingU.S. Food and Drug Administration
05
Peptide and other bulk-substance safety risksU.S. Food and Drug Administration
06
Pemvidutide study search in United StatesClinicalTrials.gov
07
NCT07009860: RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)ClinicalTrials.gov
08
NCT06987513: RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or OverweightClinicalTrials.gov
09
NCT05134662: ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)ClinicalTrials.gov
10
NCT05295875: Efficacy and Safety of ALT-801 in the Treatment of ObesityClinicalTrials.gov
11
NCT05006885: ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)ClinicalTrials.gov
Audit and handoff

Keep the exact record attached.